10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
July 27, 2021 06:30 ET | 10x Genomics, Inc.
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes  PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced that it...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics Introduces New Chromium X Series for Single Cell Analysis
July 14, 2021 08:00 ET | 10x Genomics, Inc.
PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics to Report Second Quarter Financial Results on August 4, 2021
July 07, 2021 16:03 ET | 10x Genomics, Inc.
PLEASANTON, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
June 10, 2021 08:00 ET | 10x Genomics, Inc.
PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics to Participate in Upcoming June Investor Conferences
May 24, 2021 08:00 ET | 10x Genomics, Inc.
PLEASANTON, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences: William...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics Reports First Quarter 2021 Financial Results
May 05, 2021 16:03 ET | 10x Genomics, Inc.
PLEASANTON, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2021. Recent Highlights Revenue was...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
April 29, 2021 16:05 ET | 10x Genomics, Inc.
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics to Report First Quarter Financial Results on May 5, 2021
April 08, 2021 16:05 ET | 10x Genomics, Inc.
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May...
10x_Logo_Vertical_Full Color_Digital_Full Color.jpg
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
April 01, 2021 08:30 ET | 10x Genomics, Inc.
PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new offering...
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations
March 09, 2021 08:30 ET | 10x Genomics, Inc.
City to Change Street Name to ‘Genomics Place’ PLEASANTON, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced expansion plans to support the...